Elucidating the impact of low doses of nanoformulated benznidazole in acute experimental Chagas disease

Background Chagas disease is a neglected parasitic infection caused by the protozoan Trypanosoma cruzi (T. cruzi) that affects more than 6 million people, mainly in Latin America. Benznidazole is still the drug of choice in many countries to treat it in spite of its dosage regimen and adverse sid...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rial, Marcela S., Scalise, María L., Arrúa, Eva Carolina, Esteva, Mónica I., Salomon, Claudio, Fichera, Laura E.
Formato: article artículo publishedVersion
Lenguaje:Inglés
Publicado: Public Library of Science (PLOS) 2021
Materias:
Chagas Disease
Benznidazole
Nanoparticles
Neglected Diseases
Trypanosoma cruzi
Acceso en línea:http://hdl.handle.net/2133/19919
http://hdl.handle.net/2133/19919
Aporte de:
Repositorio Hipermedial de la Universidad Nacional de Rosario (UNR) de Universidad Nacional de Rosario

Ejemplares similares

Ejemplares similares